4th Annual Immuno-Oncology 360°

4th Annual Immuno-Oncology 360° is organized by The Conference Forum and will be held during Feb 07 - 09, 2018 at The Roosevelt Hotel, New york city, New York, United States of America.

The target audience for this medical event is large pharma, mid-sized biopharma, biotechs and investors seeking to accelerate clinical trials in the emerging immuno oncology space.

Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R and D, addressing aspects from all facets of IO including:

• Discovery/Preclinical Science
• Translational Science
• Clinical Development
• Business Aspects
• Investor Relations
• Emerging Technologies
• Biomarkers / Diagnostics
• Trends in the Field

Lead Advisors Dr Axel Hoos, GSK, and Dr James Gulley, NCI, developed the 4th annual IO360° program to include 45 speakers and over 30 talks. Dr Andrew Baum is the investor relations plenary keynote.

IO360° provides the most up-to-date research, data and progress to help IO stakeholders:
• Be at the forefront of relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
• Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof?
• Receive the latest pre-clinical, translational and clinical data from academic and industry
• Gain a greater understanding of what assets are available for potential combinations
• Create and prioritize strategies targeted toward specific tumor types?
• Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
• Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next
• Hear reports on industry trends from Endpoint News and BioCentury Innovations and a progress update on the Cancer Moonshot
• Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more Obtain coverage on a wide range of emerging technologies

Pharma and Biotech Special Rate:
To support IO teams in drug development, the registration fee for pharma and biotech companies includes a guest pass for a colleague from within the same company who has not yet attended IO360°. Guest pass must be claimed by Nov. 3, 2017.

Prices:
Pharma and Biotech starting rate: USD 1895,
Standard Industry starting rate: USD 1895,
Academia, Non-Profit and Government starting rate: USD 947.50.

Speakers: James Gulley MD PhD, Axel Hoos MD PhD, Andrew Baum MD, Roy Baynes MD PhD, Ali Behbahani MD MBA, Jeff Bockman PhD, Bruce Booth DPhil, Lisa Butterfield PhD, Dario Campana MD PhD, John D Carroll, Jasmine Ferrer DPhil, Simone Fishburn PhD, Simeon George MD, William Grossman MD PhD, Laura Johnson PhD, Lanny Kirsch MD, Ron Korn MD PhD, Corey Langer MD FACP, Patrick Mayes PhD, Ian McCaffery PhD, Adam Millinger, Naiyer Rizvi MD, Greg Simon JD, Julius Strauss MD, Hiroomi Tada MD PhD, Jonathan Wan, Jeffrey Weber MD PhD, Cissy Young PhD MBA

Time: 8:00 am to 5:00 pm.

Additional details will be posted as soon as they are available.